-
Catalogue Entry: Adverse reactions, medical device incidents and health product recalls in...
Each year, Health Canada receives thousands of reports of suspected adverse reactions (side effects) about drugs and natural health products and of suspected medical device...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Submitting risk management plans draft guidance document: Canadian-specific...
A Canadian-specific addendum should address: risks or uncertainties that are unique to the Canadian context, and measures that the manufacturer intends to take that are unique...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Submitting risk management plans draft guidance document: RMP summary template
The RMP summary should include specific sections, which mirror the EU RMP Summary format sections.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Submitting risk management plans draft guidance document: Opioid products
Opioid products need to include specific content within their RMP to address: the risk and uncertainties of opioid-related harms in Canada and other risks and uncertainties...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Submitting risk management plans draft guidance document: Procedures to submit
Information on risk management plan submissions for drugs including when to file, considerations, requirements, and compliance.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Submitting risk management plans draft guidance document: Introduction
Health Canada has adopted and integrated the use of risk management plans (RMPs) and the International Conference on Harmonization (ICH) E2E Guideline into the regulatory review...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Regulatory Requirements for Advertising
Only health products that Health Canada authorizes for sale in Canada may be advertised. Specific requirements exist for advertisements of prescription drugs to consumers.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Regulating health products
Learn how Health Canada makes sure that the health products you use are safe, effective and of high quality.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Regulating Advertising of Health Products
Health Canada sets the standards for health product advertising material in Canada to help advertisers produce messages that are not false, misleading or deceptive.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Reporting adverse reactions to marketed health products - Guidance document...
This guidance document provides market authorization holders (MAHs) with assistance on how to comply with the Food and Drugs Act, the Food and Drug Regulations, and the Natural...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Optimizing the Use of Real World Evidence to Inform Regulatory Decision-Making
Health Canada’s Evolving Approach to Leveraging Real World Evidence (RWE) for Drug Regulatory Decisions.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Notice of clarification to drug manufacturers and sponsors:...
We are issuing this notice to help drug manufacturers and sponsors when preparing the Canadian-specific considerations and elements in the risk management plans (RMPs) for...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Notice of clarification to drug manufacturers and sponsors - Risk Management...
This notice is being issued to clarify to drug manufacturers and sponsors that elements of Risk Management Plans (RMPs) required by Health Canada, such as controlled...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Module 4: Health Canada’s review and communication of safety findings
Educational module provides overview of health product vigilance, report management, post-market surveillance activities and Health Canada risk communications.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Module 3: Strategies to promote and support mandatory reporting
Educational module helps identify and overcome barriers to hospital mandatory reporting of adverse drug reactions and medical device incidents, recognize opportunities and...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Module 2: Reporting processes to Health Canada
Educational module includes considerations for mandatory reporting of adverse drug reactions and medical device incidents, reporting options to Health Canada, differentiating...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Module 1: Overview of Vanessa’s Law and reporting requirements
Educational module includes an outline of Vanessa’s Law, who/what/when of regulations for mandatory reporting of adverse drug reactions and medical device incidents, required...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Let's talk about acetaminophen
Acetaminophen is safe and effective when used as directed, but there is a limit to how much you can take in one day. Taking more than the recommended dose can cause severe or...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Laser eye surgery
Thousands of Canadians are turning to laser eye surgery to correct their vision and eliminate their dependency on glasses or contact lenses. Like all medical procedures, laser...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Canada's Response to the Carlin Jury Recommendations Aimed at the...
Health Canada's top priority is protecting the health and safety of Canadians. The department has a strong record of enhancing drug safety in Canada and is continually looking...-
File available for download in the following formats:
- HTML